MMR Information Systems, Inc. (MMRF.OB) Enters Agreement with sanofi-aventis Regarding Anti-CD20 Monoclonal Antibodies
MMR Information Systems, Inc., a provider of secure and easy-to-use online personal health records and electronic safe deposit box storage solutions, recently announced that the company has entered into an agreement with sanofi-aventis China regarding MMR’s anti-CD20 monoclonal antibodies. Sanofi-aventis China is a division of the world’s third-largest pharmaceutical company in global prescription sales. Under the terms of the agreement, MMR’s antibody assets may be used in the development of future treatment options for various autoimmune and B-Cell mediated diseases, including, but not limited to, lupus nephritis, systemic lupus erythematosus, psoriasis, respiratory distress syndrome, chronic lymphocytic leukemia and multiple sclerosis.…